Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma

Cancer Immunol Immunother. 2022 Jan;71(1):121-136. doi: 10.1007/s00262-021-02967-8. Epub 2021 May 24.

Abstract

Liver cancer accounts for 6% of all malignancies causing death worldwide, and hepatocellular carcinoma (HCC) is the most common histological type. HCC is a heterogeneous cancer, but how the tumour microenvironment (TME) of HCC contributes to the progression of HCC remains unclear. In this study, we investigated the immune microenvironment by multiomics analysis. The tumour immune infiltration characteristics of HCC were determined at the genomic, epigenetic, bulk transcriptome and single-cell levels by data from The Cancer Genome Atlas portal and the Gene Expression Omnibus (GEO). An epigenetic immune-related scoring system (EIRS) was developed to stratify patients with poor prognosis. SPP1, one gene in the EIRS system, was identified as an immune-related predictor of poor survival in HCC patients. Through receptor-ligand pair analysis in single-cell RNA-seq, SPP1 was indicated to mediate the crosstalk between HCC cells and macrophages via SPP1-CD44 and SPP1-PTGER4 association. In vitro experiments further validate SPP1 can trigger the polarization of macrophages to M2-phenotype tumour-associated macrophages (TAMs).

Keywords: Crosstalk; Hepatocellular carcinoma (HCC); Prognosis; SPP1; Tumour microenvironment (TME); Tumour-associated macrophages (TAMs).

MeSH terms

  • Adult
  • Aged
  • Algorithms
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Cell Movement
  • Coculture Techniques
  • DNA Methylation
  • Disease-Free Survival
  • Female
  • Genome, Human
  • Hep G2 Cells
  • Humans
  • Immune System
  • Immunotherapy
  • Ligands
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Macrophages / metabolism*
  • Male
  • Middle Aged
  • Monocytes / metabolism
  • Osteopontin / metabolism*
  • Phenotype
  • Prognosis
  • RNA, Small Interfering / metabolism
  • Treatment Outcome
  • Tumor Microenvironment*

Substances

  • Ligands
  • RNA, Small Interfering
  • SPP1 protein, human
  • Osteopontin